Last updated on January 2019

Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors


Brief description of study

The objective of this study is to evaluate the safety and efficacy of IW-3718 administered to patients with GERD who continue to have persistent symptoms, such as heartburn and regurgitation, while receiving once-daily (QD), standarddose proton pump inhibitors (PPIs).

Clinical Study Identifier: NCT03561883

Find a site near you

Start Over

Inquest Clinical Research

Baytown, TX United States
2.46miles
  Connect »